Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

Mental Health Among Patients, Providers, and Staff During the COVID-19 Era

Lead Sponsor:

St. Luke's Health System, Boise, Idaho

Collaborating Sponsors:

Patient-Centered Outcomes Research Institute

Idaho Crisis & Suicide Hotline

Conditions:

Covid19

Mental Health

Eligibility:

All Genders

12+ years

Phase:

NA

Brief Summary

The Mental Health Among Patients, Providers, and Staff (MHAPPS) Study is designed to study how the COVID-19 pandemic has affected mental health and wellbeing, and how to support mental health while mi...

Detailed Description

Approximately 4,800 participants will complete the Aim 1 survey. The Caring Contacts intervention involves sending a series of brief, non-demanding, supportive text messages to the participant. One in...

Eligibility Criteria

Inclusion

  • Aim 1:
  • Provider \& Employee Inclusion Criteria
  • Provider or Employee at St. Luke's Health System
  • Adults ≥ 18 years of age
  • Proficient in spoken and written English language
  • Patient Inclusion Criteria
  • Patient at a St. Luke's Health System primary care site
  • Current MyChart account user
  • Adults ≥18 years of age
  • Minors 12-17 years of age
  • Proficient in spoken and written English language
  • Aim 2:
  • Provider \& Employee Inclusion Criteria
  • Moderate or high score for loneliness, suicide ideation, psychological stress, anxiety, or depression:
  • NIH Toolkit Loneliness raw score of 13 or greater or
  • C-SSRS score of 3 or greater; or
  • NIH Toolkit Perceived Stress raw score of 31 or greater for adults; or
  • GAD7 score of 11 or greater; or
  • PHQ9 score of 10 or greater
  • Access to a phone for the duration of the study with the ability to receive text messages and phone calls
  • Patient Inclusion Criteria
  • Moderate or high score for loneliness, suicide ideation, psychological stress, anxiety, or depression:
  • NIH Toolkit Loneliness raw score of 13 or greater for adults or 16 or greater for adolescents; or
  • C-SSRS score of 3 or greater; or
  • GAD7 score of 11 or greater; or
  • PHQ9 score of 10 or greater; or
  • NIH Toolkit Stress raw score of 31 or greater for adults or 33 or greater for adolescents
  • \[Note: validated youth versions of the NIH Toolkit assessments (loneliness and perceived stress), and PHQ-A tools will be used for adolescents; the C-SSRS and GAD7 tools are validated for use with both adults and adolescents.\]
  • Access to a phone for the duration of the study with the ability to receive text messages and phone calls

Exclusion

  • Aim 1:
  • Provider \& Employee Exclusion Criteria
  • Individuals who are unable or unwilling to provide informed consent to participate
  • Individuals who are study staff for this study or the SPARC Trial
  • Patient Exclusion Criteria
  • Individuals who are unable or unwilling to provide informed consent to participate.
  • Individuals who are participants in the SPARC Trial
  • Individuals who have not had a primary care visit in the past 12 months
  • Aim 2:
  • Provider \& Employee Exclusion Criteria
  • Individuals who are unable or unwilling to provide informed consent to participate
  • Individuals who are in acute crisis as determined by the person conducting the consent process
  • Individuals who are study staff for this study or the SPARC Trial
  • Individuals who are enrolled as participants in the SPARC comparative effectiveness clinical trial (SPARC Aim 1). Providers or employees who received training related to SPARC and/or who completed the SPARC provider satisfaction survey are not excluded from participating in MHAPPS
  • Patient Exclusion Criteria
  • Patients who are unable or unwilling to provide informed consent/assent to participate (or whose legally authorized representative is unable or unwilling to provide consent in the case of adolescents). Examples may include but are not limited to patients who present with acute or chronic cognitive impairment that would preclude their ability to consent (i.e. acute psychosis, intoxication, or intellectual disability).

Key Trial Info

Start Date :

January 18 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 6 2022

Estimated Enrollment :

666 Patients enrolled

Trial Details

Trial ID

NCT04700137

Start Date

January 18 2021

End Date

January 6 2022

Last Update

January 25 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St. Luke's Health System

Boise, Idaho, United States, 83712